Genital Papillomavirus Infection in Women Treated for Chlamydial Infection

1992 ◽  
Vol 3 (1) ◽  
pp. 42-45 ◽  
Author(s):  
A Andersson-Ellström ◽  
L Forssman
Keyword(s):  
Chlamydial Infection ◽  
Pap Smear ◽  
Young Patients ◽  
Pap Smears ◽  
Sexually Active ◽  
Papillomavirus Infection ◽  
Pap Smear Screening ◽  
Vaginal Cytology ◽  
Cytological Changes

Samples for chlamydia testing were taken from 298 and PAP smear from 284 non-pregnant sexually active young women in a midwife-run family planning service. Chlamydia was found in 36 (12.1%). Three women (1.1%) had cytological atypia corresponding to CIN I or II. Koilocytosis was seen in 9 smears (2.8%). Thirty-two of the chlamydia-positive women were followed for a mean of 15 months by a gynaecologist with chlamydia tests, colposcopy, PAP-smears and in some cases biopsies. There were 7 reinfections with chlamydia (22%). Signs of genital papillomavirus infection (GPVI) were found in 24 of the 32 chlamydia cases during follow-up. Twenty chlamydia-positive patients had abnormal colposcopy, 15 of them had other changes suggestive of GPVI, seven of these had CIN I or II. At follow-up 6 patients had cytologic atypia (18.8%) compared with the average 1.5% in this department during this period. Among 12 patients with normal colposcopy there were no cytological changes. Chlamydial infection calls for increased alertness regarding abnormal vaginal cytology even among young patients not commonly included in PAP smear screening programmes.

Pap Hub: A system to improve compliance with pap smear screening guidelines in a large health care system.

2013 ◽  
Vol 31 (31_suppl) ◽  
pp. 193-193
Author(s):  
Deanna Gek Koon Teoh ◽  
Lisa A. Fall ◽  
Erin A. Beitelspacher ◽  
Charles W. Lais
Keyword(s):  
Cervical Cancer ◽  
Pap Smear ◽  
Tracking System ◽  
Invasive Cervical Cancer ◽  
The United States ◽  
Pap Smears ◽  
Health Maintenance ◽  
Screening Guidelines ◽  
Pap Smear Screening

193 Background: Cervical cancer is the most prevalent gynecologic cancer worldwide, but is third in the U.S. due to pap smear screening. However, American Society for Colposcopy and Cervical Pathology (ASCCP) guidelines are complex and frequently changed, resulting in guideline adherence as low as 33-44%. We describe a centralized pap smear tracking system (“pap hub”) and report preliminary results. Methods: On 1/1/13 we implemented the pap hub, routing all screening pap smear results to a dedicated OB/Gyn nursing staff with a new Epic workbench. Epic Health Maintenance Modifier updated to recommend pap smears for women age 21-65 years (not younger or older per guidelines). Screening Pap/HPV results auto routed to Pap Pool Epic inbasket (not to individual providers). Centralized nurse reviews results alongside past pap results on Pathology flowsheet in Epic If normal Normal history -> appropriate follow-up interval per screening guidelines If abnormal history -> repeat pap as determined by previous history and treatment If abnormal -> manage per ASCCP guidelines Document plan in Epic Result Note Update Epic problems list If Normal: document “Pap Hub Normal History” If Abnormal: document “Pap Hub Abnormal History” with specifics in Overview History Communicate results/plan to the patient. Update Health Maintenance Modifier with next step. Review abnormal results to ensure proper follow-up, with reminders as indicated. Results: Guideline recommendations against pap smears for patients <21 years and >65 years have not changed since 2009. Comparison of first-quarter data for 2010 (pre-Pap Hub) to 2013 (post-Pap Hub) have shown a 63.86% reduction in pap smears in women <21 years. Pap smears in women >65 years has always been low, but has decreased slightly from 2.4% of all pap smears in 2010 to 1.5% of all pap smears in 2013. The 2012 ASCCP guidelines have changed recommended pap smear frequency and abnormal pap smear follow-up, and compliance with these new recommendations is being collected. Conclusions: Pap smear screening has decreased the incidence of invasive cervical cancer in the United States. The Pap Hub, a centralized pap smear tracking system, improves compliance with pap smear screening guidelines.

Effects of a Videotape Intervention on Pap Smear Knowledge, Attitudes and Behaviour

1990 ◽  
Vol 7 (3) ◽  
pp. 143-150 ◽  
Author(s):  
Sian O'Brien ◽  
Christina Lee
Keyword(s):  
Cervical Cancer ◽  
Pap Smear ◽  
Health Belief ◽  
Pap Smears ◽  
Medical Practitioners ◽  
Pap Smear Screening ◽  
Post Test ◽  
Belief Model ◽  
Smear Testing

This study assessed the capacity of modelling videotapes to promote Pap smear screening. A total of 245 women watched videotapes modelling the process of Pap smear testing, and completed pre- and post-questionnaires which assessed knowledge and attitudes relating to Pap smears and cervical cancer. 186 also completed follow-up questionnaires five weeks later. Behavioural effects were strong. One third of those women identified as due for a Pap smear reported having had the test by follow-up. Initial levels of knowledge of Pap smears and of risk factors for cervical cancer were low, but increased significantly at post-test and follow-up. Health Belief Model variables, particularly perceived barriers, were associated with reported Pap smear behaviour, but a large proportion of the variance remained unexplained. The results suggest that modelling videotapes of this type, combined with appropriate encouragement and reassurance from medical practitioners, could significantly increase Pap smear rates and thus increase the detection and treatment of cervical cancer in its early stages.

scholarly journals HPV and Cytology Testing in Women Undergoing 9-Valent HPV Opportunistic Vaccination: A Single-Cohort Follow Up Study

Vaccines ◽  
2021 ◽  
Vol 9 (6) ◽  
pp. 643
Author(s):  
Rosa De Vincenzo ◽  
Nicola Caporale ◽  
Valentina Bertoldo ◽  
Caterina Ricci ◽  
Maria Teresa Evangelista ◽  
...  
Keyword(s):  
Pap Smear ◽  
Cox Regression ◽  
Vaccine Dose ◽  
Pap Smears ◽  
Adult Women ◽  
Sexually Active ◽  
Time Intervals ◽  
Dose Administration ◽  
Before And After ◽  
Single Cohort

Background: This study evaluates the possible effect of 9-valent (9vHPV) vaccination on the results of HPV and cytological tests in a cohort of adult women. Methods: This study is a retrospective, single-cohort, monocentric study. Sexually active women aged 14–70 years, who underwent 9vHPV vaccination, were enrolled. Dose administration dates, side effects and data on Pap smears and HPV tests performed before and after the first vaccine dose were collected. Subjects were considered “unexposed” to the vaccine for all time intervals before the first dose administration, and “exposed” to the first, second and third vaccine doses in all time intervals following each specific dose. Results: A total of 512 women underwent the first 9vHPV dose administration and were enrolled in the study. Median age at vaccination was 30.5 (14–70). Log-rank tests and Cox regression analyses showed a highly statistically significant (p < 0.0001) difference in the time to negativization after the exposure to the third vaccine dose in the 207 women starting with a Pap+ smear (HR (95% C.I.), 2.66 (1.83–3.86)) and in the 198 women starting with an HPV HR+ test (HR (95% C.I.), 7.80 (4.83–12.60)). Conclusions: 9vHPV vaccination may play a role in shortening the clearance time of HPV HR+ or Pap positivity in sexually active adult women.

scholarly journals Family Planning Provider Referral, Facilitation Behavior, and Patient Follow-up for Abnormal Pap Smears

2009 ◽  
Vol 124 (5) ◽  
pp. 733-744 ◽  
Author(s):  
Holly C. Felix ◽  
Janet Bronstein ◽  
Zoran Bursac ◽  
M. Kathryn Stewart ◽  
H. Russell Foushee ◽  
...  
Keyword(s):  
Family Planning ◽  
Pap Smear ◽  
Health Department ◽  
Institutional Setting ◽  
Pap Smears ◽  
Title X ◽  
Rural Location ◽  
Factors Associated ◽  
Follow Up Care

Objectives. Family planning (FP) clinics are important access points for cervical cancer screening and referrals for follow-up care for abnormal Papanicolaou (Pap) smears for a substantial number of U.S. women. Because little is known about referral and facilitation practices in these clinics or client action based on referrals, we sought to determine FP provider referral and facilitation practices when seeing FP clients with abnormal Pap smear results, and FP client follow-up for abnormal Pap smears due to FP provider referrals. Methods. We conducted a mail survey of Medicaid-enrolled FP providers in Arkansas and Alabama, and conducted a telephone survey with a sample of FP clients of those providers responding to the provider survey. Results. Major provider factors associated with referral included rural location, health department and clinic institutional setting, large Title X practice/clinic size, and high FP clinic focus. Major factors associated with facilitation included rural location, non-physician specialty, health department and clinic institutional setting, and small Title X clinic size. Of women reporting abnormal results, 62.4% reported follow-up care. Of those who received follow-up care, 40.0% received some care and a referral from their FP provider. A major factor associated with clients seeking follow-up care was being told by their FP provider where to go for follow-up care. Age was a major factor associated with clients actually obtaining follow-up care. Conclusions. Where follow-up care is not available at the FP site, referrals are critical and are a major factor associated with whether women seek care for the condition. Interventions to increase follow-up rates should focus on provider and system features, rather than clients.

Factors associated with regression of cervical dysplasia in adolescents: A retrospective study

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. 5582-5582
Author(s):  
C. Chen ◽  
F. Campbell ◽  
J. Patruno ◽  
S. Kimmel ◽  
R. Boulay ◽  
...  
Keyword(s):  
Multivariate Analysis ◽  
Pap Smear ◽  
Demographic Data ◽  
Cervical Dysplasia ◽  
Smoking History ◽  
Pap Smears ◽  
Factors Associated ◽  
Increased Risk ◽  
Chi Square Analysis

5582 Background: Sexually active adolescents have high rates of infection with human papilloma virus (HPV) and abnormal pap smears. They are considered a special population as they are likely to regress to normal cytology. The aim of our study was to identify factors associated with regression of cervical dysplasia in adolescents. Methods: We identified adolescent patients (aged 12–21 years) who had abnormal pap smears at the Center for Women's Medicine at Lehigh Valley Hospital in Allentown, PA, by CPT code from a database between Jan 2004 and Dec 2006. A chart review was performed to capture demographic data, cytology, smoking history, number of sexual partners, parity, race, contraceptive choice, use of barrier contraception. Chi-square analysis with logistic regression and multivariate analysis were used to identify factors associated with regression of cervical dysplasia. Results: Two-hundred two patients were identified. Mean age was 18.84 years (14–22 years). One hundred twenty-two (57.8%) were Hispanic, 71 (33.6%) Caucasian, and 16 (7.6%) Black. Fifty-two (24.6%) were pregnant at the time of diagnosis. Seventy-six (36%) were smokers. There were 125 (61.9%) cases of ASCUS, 33.7% (68 cases) LGSIL and 4.5% (9 cases) HGSIL on initial pap smear. One hundred eighteen (55.9%) patients had colposcopy, and of these, 32 (15.2%) had surgical intervention. Follow-up demonstrated that 72 (57.6%) patients had disease regression, 24 (19.2%) persistence and 29 (23.2%) progression. On multivariate analysis, patients who did not smoke were significantly more likely to show regression of cervical dysplasia on pap smear than women who smoked (OR 2.17, 95% CI 1.03–4.55, p = 0.039). Other factors were not statistically significant in predicting regression of cervical dysplasia. Conclusions: Adolescents who smoke were more likely to have persistent cervical dysplasia than non-smoking adolescents, putting smokers at an increased risk of advanced disease. We suggest that this subset have follow-up at shorter intervals and be enrolled in a smoking cessation program. No significant financial relationships to disclose.

scholarly journals Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women

2015 ◽  
Vol 15 (1) ◽  
Author(s):  
Samira Zoa Assoumou ◽  
Barthelemy Mabika Mabika ◽  
Angelique Ndjoyi Mbiguino ◽  
Mustapha Mouallif ◽  
Abdelkim Khattabi ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Human Papillomavirus ◽  
Pap Smear ◽  
Human Papillomavirus Infection ◽  
Papillomavirus Infection ◽  
Pap Smear Screening

STUDY AND ANALYSIS OF CERVICAL PAP SMEARS IN A MEDICAL COLLEGE HOSPITAL

2021 ◽  
pp. 31-33
Author(s):  
S. Preetika ◽  
Sahayaraj Sahayaraj
Keyword(s):  
Cervical Cancer ◽  
Pap Smear ◽  
Age Groups ◽  
Pap Test ◽  
Developed Countries ◽  
Pap Smears ◽  
Cervical Lesions ◽  
College Hospital ◽  
Medical College ◽  
Pap Smear Screening

Introduction: Cervical cancer is the second most common gynaecological cancer worldwide and the third leading cause of cancer-related mortality in the less developed countries. Cervical cancer may be prevented or diagnosed at early stages due to the easy accessibility and clinical evaluation of the cervix. A pap test is a simple, easy, painless procedure which can be carried out as an outpatient procedure to detect specic, nonspecic inammations, precancerous and cancerous lesions In our study we have analysed the results of PAP smears of women in all age groups and have tried to evaluate the prevalence of cervical lesions and the importance of cervical cancer screening. Material And Methods: Our study was conducted between October 2020 to JULY 2021 and patients who have visited the Gynaec OP during this period were included for this study. We received Pap smears from the Department of Obstetrics and Gynecology, stained the slides with Pap stain and studied the smears according to the new Bethesda System for Reporting Cervical Cytology 2014. Results: In our study, majority of the patients were in the age group of 41-50 years. Smears showing ASCUS were 14 , LSIL reports were 5, HSIL reports were 4. No Smears showed squamous cell carcinoma in our study. Reports in our study like many other studies has shown the importance of Pap smear test in screening cervical cancer. By conducting health camps, increasing health awareness and performing Pap smear screening programmes the incidence of cervical carcinoma can be decreased.

scholarly journals Pap smear screening: a retrospective study

2017 ◽  
Vol 6 (4) ◽  
pp. 1299
Author(s):  
Anjali Soni
Keyword(s):  
Retrospective Study ◽  
Cervical Carcinoma ◽  
Screening Test ◽  
Pap Smear ◽  
High Specificity ◽  
Cost Effective ◽  
Medical College ◽  
Appropriate Treatment ◽  
Pap Smear Screening

Background: Cervical cancer is the seventh cancer in overall frequency, but the second most common cancer among women worldwide. The objective was to study the population undergoing pap-smear screening.Methods: It is retrospective study conducted in general hospital, GMERS Medical College Gotri, Gujarat, India. Total 1003 patients who attended OPD have undergone routine pap smear screening over period of 6 months from January 2016 to June 2016. Cytotological examination was done and test results were classified according to Bethesda system.Results: Abnormal tests were found in 36 patients.Conclusions: Pap smear a routine screening test offered to every woman who comes to our OPD irrespective of her complaints. Every woman at least once in her lifetime should go for pap-smear examination. It is effective screening test for cervical carcinoma. It is cost effective test with high specificity and very easy to perform so it becomes the method of choice for cervical carcinoma screening. With proper follow up patients with abnormal tests are screened and appropriate treatment is being offered to patients.

31. WHY HAS TRICHOMONAS VAGINALIS DECLINED DRAMATICALLY AMONG VICTORIAN WOMEN (1947-2005)?

Sexual Health ◽  
2007 ◽  
Vol 4 (4) ◽  
pp. 296
Author(s):  
J. Marrone ◽  
C. K. Fairley ◽  
M. Saville ◽  
C. Bradshaw ◽  
F. J. Bowden ◽  
...  
Keyword(s):  
Sexual Behaviour ◽  
Similar Pattern ◽  
Trichomonas Vaginalis ◽  
Pap Smear ◽  
Health Centre ◽  
Pap Smears ◽  
Victorian Women ◽  
Screening Participation ◽  
Pap Smear Screening ◽  
Notification Data

Trichomonas vaginalis (TV) diagnosis rates have decreased considerably in some countries during the last two decades. It is unclear why TV has decreased only in some countries. This study investigated the relationships between: 1) TV diagnosis rates among women attending the Melbourne Sexual Health Centre (MSHC), and among Pap smears screened by Victorian Cytology Services (VCS); 2) the use of nitroimidazoles in Australia and; 3) gonorrhoea notification data for Victoria to assess changes in sexual behaviour. TV diagnosis rates among women attending MSHC rose from under 5% in the 1940's, to 20% to 30% in the 1960's and then declined 5% to 10% during the 1970's. From 1980 onwards, TV diagnosis rates fell progressively to below 1% by 1991, with 0.1% in 2004. A similar pattern was seen in TV at VCS, but with lower absolute percentages. Metronidazole was introduced into Australia in 1961 and tinidazole in 1976 and by 1987 there were 400 000 nitroimidazole prescriptions per year. Pap smear screening in Victoria began in 1965, only including 20% of women per year (aged 15 to 69) by the mid 1980's. Post 1980's, screening rose until 2000, stabilising at 35% of women per year. Gonorrhoea notification rates peaked during times TV was experiencing its greatest falls. The initial decline of TV seen in Victoria was associated with the introduction of effective antibiotics. The further decline to less than 1% was seen when Pap smear screening participation increased during the 1990's.

Other Causes of Red Urine

1984 ◽  
Vol 5 (9) ◽  
pp. 273-273
Author(s):  
T. SILBER
Keyword(s):  
Young Patients ◽  
Sexually Active ◽  
Gross Hematuria ◽  
Macroscopic Hematuria ◽  
Urethral Discharge ◽  
Male Adolescents ◽  
Procaine Penicillin ◽  
Sufficient Cause ◽  
Work Up

An increasing number of pediatricians are following their young patients throughout adolescence. For that reason, I would like to add one more cause of hematuria to the list developed by Kaplan: gonococcal infection. Gonorrhea is the second most common cause of gross hematuria in adults. Recently, our group had the opportunity to describe this same condition in male adolescents. It is important to suspect that gonorrhea may be the cause of macroscopic hematuria in otherwise healthy, sexually active adolescent males who on history or physical examination demonstrate purulent urethral discharge, dysuria, or both. The toxic action of Neisseria gonorrhoeae on the urethral epithelium is sufficient cause to explain the hematuria. A follow-up visit, one week after treatment with 4.8 million units of procaine penicillin and 1 gm of probenecid (or 3 gm of amoxicillin and 1 gm of probenecid) should show resolution of symptoms and clearing of the macrohematuria. Further work-up is needed only if symptoms have not cleared at the time of the test-for-cure visit.

Sign in / Sign up

Export Citation Format

Share Document